- Previous Close
1.5000 - Open
1.5200 - Bid 1.0800 x 200
- Ask 1.7500 x 200
- Day's Range
1.3539 - 1.6400 - 52 Week Range
1.2700 - 5.8500 - Volume
25,309 - Avg. Volume
19,754 - Market Cap (intraday)
5.862M - Beta (5Y Monthly) 2.95
- PE Ratio (TTM)
0.04 - EPS (TTM)
31.9100 - Earnings Date May 12, 2025 - May 16, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
4.00
Ontrak, Inc. operates as an artificial intelligence powered, telehealth-enabled, and virtualized healthcare company that provides in-person services to third-party payors in the United States. Its technology-enabled platform predicts people whose chronic disease will improve with behavior change, recommends effective care pathways that people are willing to follow, and engages and guides them to and through the care they need. The company's technology enabled OnTrak program provides healthcare solutions to members with behavioral conditions that cause or exacerbate chronic medical conditions, such as diabetes, hypertension, coronary artery disease, chronic obstructive pulmonary disease, and congestive heart failure. The OnTrak integrates evidence-based psychosocial and medical interventions delivered in-person or via telehealth along with care coaching and in-market community care coordinators, who address the social and environmental determinants of health. The company was formerly known as Catasys, Inc. and changed its name to Ontrak, Inc. in July 2020. Ontrak, Inc. was incorporated in 2003 and is headquartered in Miami, Florida.
www.ontrakhealth.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: OTRK
View MorePerformance Overview: OTRK
Trailing total returns as of 4/16/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: OTRK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: OTRK
View MoreValuation Measures
Market Cap
6.33M
Enterprise Value
6.46M
Trailing P/E
0.05
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.50
Price/Book (mrq)
0.55
Enterprise Value/Revenue
0.57
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-235.01%
Return on Assets (ttm)
-53.46%
Return on Equity (ttm)
-211.17%
Revenue (ttm)
10.85M
Net Income Avi to Common (ttm)
-79.02M
Diluted EPS (ttm)
31.9100
Balance Sheet and Cash Flow
Total Cash (mrq)
5.71M
Total Debt/Equity (mrq)
95.25%
Levered Free Cash Flow (ttm)
-12.35M